New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...

At 24 months, endocrine therapy appeared to have a more negative effect on HRQOL as measured by the global health status (GHS ...

Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.

It’s been long known that women with BRCA1 and BRCA2 gene mutations are at higher risk for breast and ovarian cancer. More ...

Black women experience advanced diagnoses 55% more often than white women and are more likely to die from the disease, the ...

Outside experts say, however, that the choice of control group in the trial may limit the relevance to clinical practice.

Some early breast cancer patients can safely avoid certain surgeries. That's according to two studies published Thursday that ...

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

A HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...

SAN ANTONIO -- The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy ...

Victoria Ekanoye is a breast cancer and sicklecell advocate, She is filming a documentary called Shades of Survival around ...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...